Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Nuñez, W. Buño (1999)
In vitro electrophysiological properties of rat dorsal column nuclei neuronsEuropean Journal of Neuroscience, 11
K. Hager, M. Kenklies, J. Mcafoose, J. Engel, G. Münch (2007)
α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysisJournal of Neural Transmission-supplement, 72
V. Srinivasan, S. Pandi‑Perumal, G. Maestroni, A. Esquifino, R. Hardeland, D. Cardinali (2009)
Role of melatonin in neurodegenerative diseasesNeurotoxicity Research, 7
C. Geula, N. Nagykery, A. Nicholas, Chuang‐Kuo Wu (2008)
Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 67
W. Samuel, R. Terry, R. DeTeresa, N. Butters, E. Masliah (1994)
Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.Archives of neurology, 51 8
D. Christensen, S. Kraus, A. Flohr, M. Cotel, O. Wirths, T. Bayer (2008)
Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI miceActa Neuropathologica, 116
A. Martínez, E. Fernández, A. Castro, S. Conde, I. Rodriguez-Franco, J. Baños, A. Badía (2000)
N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors.European journal of medicinal chemistry, 35 10
J. Gutiérrez‐Cuesta, M. Tajes, A. Jiménez, A. Coto-Montes, A. Camins, M. Pallàs (2008)
Evaluation of potential pro‐survival pathways regulated by melatonin in a murine senescence modelJournal of Pineal Research, 45
D. Acuña-Castroviejo, G. Escames, M. Rodríguez, L. López (2007)
Melatonin role in the mitochondrial function.Frontiers in bioscience : a journal and virtual library, 12
Julia Chung, J. Cummings (2000)
Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment.Neurologic clinics, 18 4
Carmela Germano, G. Kinsella (2005)
Working Memory and Learning in Early Alzheimer’s DiseaseNeuropsychology Review, 15
Rong-Yu Liu, Jiang-Ning Zhou, J. Heerikhuize, M. Hofman, D. Swaab (1999)
Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.The Journal of clinical endocrinology and metabolism, 84 1
S. Scheff, S. DeKosky, D. Price (1990)
Quantitative assessment of cortical synaptic density in Alzheimer's diseaseNeurobiology of Aging, 11
Zheng Feng, C. Qin, Yang Chang, Jun‐tian Zhang (2006)
Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.Free radical biology & medicine, 40 1
Hong-yu Zhang, Da-Peng Yang, Guang-Yan Tang (2006)
Multipotent antioxidants: from screening to design.Drug discovery today, 11 15-16
P. Tiraboschi, L. Hansen, M. Alford, E. Masliah, L. Thal, J. Corey-Bloom (2000)
The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s diseaseNeurology, 55
E García-Palomero, P Muñoz, P Usan, P Garcia, E Delgado, C Austria, R Valenzuela, L Rubio, M Medina, A Martínez (2008)
Potent beta-amyloid modulatorsNeurodegener Dis, 5
U. Holzgrabe, Petra Kapková, Vildan Alptüzün, J. Scheiber, E. Kugelmann (2007)
Targeting acetylcholinesterase to treat neurodegenerationExpert Opinion on Therapeutic Targets, 11
M. Polidori (2004)
Oxidative stress and risk factors for Alzheimer's disease: clues to prevention and therapy.Journal of Alzheimer's disease : JAD, 6 2
Robert Lalonde, H. Kim, K. Fukuchi (2004)
Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 miceNeuroscience Letters, 369
T. Gorfine, Y. Yeshurun, N. Zisapel (2007)
Nap and melatonin‐induced changes in hippocampal activation and their role in verbal memory consolidationJournal of Pineal Research, 43
Chuang‐Kuo Wu, L. Thal, D. Pizzo, Lawrance Hansen, E. Masliah, C. Geula (2005)
Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's diseaseExperimental Neurology, 195
T. Vargas, C. Ugalde, C. Spuch, D. Antequera, M. Morán, Miguel Martín, I. Ferrer, F. Bermejo‐Pareja, E. Carro (2010)
Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosisNeurobiology of Aging, 31
E. Carro, J. Trejo, T. Gómez-Isla, D. Leroith, I. Torres-Alemán (2002)
Serum insulin-like growth factor I regulates brain amyloid-β levelsNature Medicine, 8
M. Engelhart, M. Geerlings, A. Ruitenberg, J. Swieten, A. Hofman, J. Witteman, M. Breteler (2002)
Dietary intake of antioxidants and risk of Alzheimer disease.JAMA, 287 24
X. Zhu, B. Su, X. Wang, M. Smith, George Perry (2007)
Causes of oxidative stress in Alzheimer diseaseCellular and Molecular Life Sciences, 64
A. Vega, W. Buño, S. Pons, M. Garcia-Calderat, E. García-galloway, I. Torres-Alemán (2001)
Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathwayNeuroreport, 12
D. Lahiri (1999)
Melatonin affects the metabolism of the β‐amyloid precursor protein in different cell typesJournal of Pineal Research, 26
M. Rodríguez-Franco, M. Fernández-Bachiller, C. Pérez, B. Hernández-Ledesma, B. Bartolomé (2006)
Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.Journal of medicinal chemistry, 49 2
J. Quinn, J. Suh, M. Moore, J. Kaye, B. Frei (2003)
Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain.Journal of Alzheimer's disease : JAD, 5 4
P. Moreira, Maria Santos, C. Oliveira, J. Shenk, A. Nunomura, Mark Smith, Xiongwei Zhu, George Perry (2008)
Alzheimer disease and the role of free radicals in the pathogenesis of the disease.CNS & neurological disorders drug targets, 7 1
M. Rodríguez-Franco, M. Fernández-Bachiller (2002)
1-Benzyl-4-chloromethylpiperidine: A Building Block in the Synthesis of Compounds of Pharmacological InterestSynthesis, 2002
R. Raschetti, E. Albanese, N. Vanacore, M. Maggini (2007)
Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised TrialsPLoS Medicine, 4
H. Fu, Wenming Li, Y. Lao, Jialie Luo, N. Lee, Kelvin Kan, Hing Tsang, K. Tsim, Y. Pang, Zhi-wang Li, D. Chang, Mingtao Li, Yifan Han (2006)
Bis(7)‐tacrine attenuates β amyloid‐induced neuronal apoptosis by regulating L‐type calcium channelsJournal of Neurochemistry, 98
M. Fernández-Bachiller, C. Pérez, N. Campillo, J. Páez, Gema González-Muñoz, P. Usán, E. Garcı́a-Palomero, Manuela López, M. Villarroya, Antonio García, Ana Martínez, M. Rodríguez-Franco (2009)
Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective PropertiesChemMedChem, 4
J. Masilamoni, E. Jesudason, S. Dhandayuthapani, B. Ashok, S. Vignesh, W. Jebaraj, Solomon Paul, R. Jayakumar (2008)
The neuroprotective role of melatonin against amyloid β peptide injected miceFree Radical Research, 42
Mingzhong Yao, Thuy-vi Nguyen, C. Pike (2005)
β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-wThe Journal of Neuroscience, 25
J. Luchsinger, M. Tang, S. Shea, R. Mayeux (2003)
Antioxidant vitamin intake and risk of Alzheimer disease.Archives of neurology, 60 2
M. Rodríguez-Franco, Isabel Dorronsoro, Ana Martínez (2001)
O-Pyrazolylpropynyl-Hydroxylamines as Versatile Intermediates in the Synthesis of Compounds of Pharmacological InterestSynthesis, 2001
H. Fu, Wenming Li, Jialie Luo, N. Lee, Mingtao Li, K. Tsim, Y. Pang, M. Youdim, Yifan Han (2008)
Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.Biochemical and biophysical research communications, 366 3
P. Raina, P. Santaguida, A. Ismaila, C. Patterson, D. Cowan, Mitch Levine, L. Booker, M. Oremus (2008)
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice GuidelineAnnals of Internal Medicine, 148
Zheng Feng, Yang Chang, Yong Cheng, Bin-ling Zhang, Zhi-wei Qu, Chuan Qin, Jun‐tian Zhang (2004)
Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's diseaseJournal of Pineal Research, 37
P. Modrego (2006)
The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques.Current medicinal chemistry, 13 28
S. Pons, I. Torres-Alemán (2000)
Insulin-like Growth Factor-I Stimulates Dephosphorylation of IκB through the Serine Phosphatase Calcineurin (Protein Phosphatase 2B)*The Journal of Biological Chemistry, 275
E. Matsubara, Tara Bryant‐Thomas, Javier Quinto, Tracey Henry, B. Poeggeler, D. Herbert, F. cruz-Sánchez, Y. Chyan, Mark Smith, George Perry, M. Shoji, K. Abe, A. Leone, Inge Grundke-Ikbal, G. Wilson, J. Ghiso, Christina Williams, L. Refolo, M. Pappolla (2003)
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's diseaseJournal of Neurochemistry, 85
M. Rodríguez-Franco, M. Fernández-Bachiller, C. Pérez, A. Castro, Ana Martínez (2005)
Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.Bioorganic & medicinal chemistry, 13 24
Hsueh‐Meei Huang, Hui Zhang, H. Ou, Hua-Lian Chen, G. Gibson (2004)
α-KETO-ß-METHYL-n-VALERIC ACID DIMINISHES REACTIVE OXYGEN SPECIES AND ALTERS ENDOPLASMIC RETICULUM Ca2+ STORESFree Radical Biology and Medicine, 37
G. Frisoni, L. Rozzini, A. Gozzetti, G. Binetti, O. Zanetti, A. Bianchetti, M. Trabucchi, J. Cummings (1999)
Behavioral Syndromes in Alzheimer’s Disease: Description and CorrelatesDementia and Geriatric Cognitive Disorders, 10
Weihong Song, D. Lahiri (1997)
Melatonin alters the metabolism of the β-amyloid precursor protein in the neuroendocrine cell line PC12Journal of Molecular Neuroscience, 9
K. Krishnan, H. Charles, P. Doraiswamy, J. Mintzer, R. Weisler, Xin Yu, C. Perdomo, John Ieni, Sharon Rogers (2003)
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.The American journal of psychiatry, 160 11
M. Dietrich, C. Spuch, Dessire Antequera, Izaskun Rodal, J. Yébenes, J. Molina, F. Bermejo, E. Carro (2008)
Megalin mediates the transport of leptin across the blood-CSF barrierNeurobiology of Aging, 29
E. Garcı́a-Palomero, P. Muñoz, P. Usán, Pablo García, Elena Delgado, C. Austria, Rita Valenzuela, Laura Rubio, Miguel Medina, Ana Martinez (2008)
Potent β-Amyloid ModulatorsNeurodegenerative Diseases, 5
Alzheimer’s disease (AD) is a progressive degenerative disorder characterized by the presence of amyloid deposits, neurofibrillary tangles and neuron loss. Emerging evidence indicates that antioxidants could be useful either for the prevention or treatment of AD. Tacrine and melatonin are well-known drugs which act as an acetylcholinesterase inhibitor and a free radical scavenger, respectively. In this study, we evaluated the effects of a new tacrine–melatonin hybrid on behavior and the biochemical and neuropathologic changes observed in amyloid precursor protein/presenilin 1 (APP/Ps1) transgenic mice. Our findings showed that direct intracerebral administration of this hybrid decreased amyloid β peptide (Aβ)-induced cell death and amyloid burden in the brain parenchyma of APP/Ps1 mice. This reduction in Aβ pathology was accompanied by a recovery in cognitive function. Since this tacrine–melatonin hybrid apparently reduces brain Aβ and behavioral deficits, we believe this drug has remarkable and significant neuroprotective effects and might be considered a potential therapeutic strategy in AD.
Neurotoxicity Research – Springer Journals
Published: Sep 23, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.